Of note, the checkpoint receptor PD-1 was elevated on CD4+ and CD8+ T cells infiltrating C-GBM tumors, as were CD32, CD69, CD44, and HLA-DR on C-GBM–infiltrating peripheral MDMs. This evidence concerns the gene PDCD1 and glioblastoma.